KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Account Payables: 2009-2025

Historic Change in Account Payables for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Sep 2025 value amounting to -$3.4 million.

  • Rigel Pharmaceuticals' Change in Account Payables fell 48.77% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31,000, marking a year-over-year increase of 100.74%. This contributed to the annual value of -$3.8 million for FY2024, which is 939.07% down from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Change in Account Payables is -$3.4 million, which was down 203.24% from $3.3 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Change in Account Payables high stood at $4.8 million for Q4 2022, and its period low was -$3.4 million during Q3 2025.
  • Its 3-year average for Change in Account Payables is -$332,909, with a median of -$857,000 in 2023.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Change in Account Payables crashed by 383.68% in 2021, and later soared by 586.80% in 2022.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Change in Account Payables stood at $697,000 in 2021, then spiked by 586.80% to $4.8 million in 2022, then slumped by 117.90% to -$857,000 in 2023, then surged by 44.46% to -$476,000 in 2024, then plummeted by 48.77% to -$3.4 million in 2025.
  • Its Change in Account Payables was -$3.4 million in Q3 2025, compared to $3.3 million in Q2 2025 and $615,000 in Q1 2025.